BR0311866A - Composições de saponinas ou sapogeninas para terapia de câncer - Google Patents

Composições de saponinas ou sapogeninas para terapia de câncer

Info

Publication number
BR0311866A
BR0311866A BR0311866-5A BR0311866A BR0311866A BR 0311866 A BR0311866 A BR 0311866A BR 0311866 A BR0311866 A BR 0311866A BR 0311866 A BR0311866 A BR 0311866A
Authority
BR
Brazil
Prior art keywords
compositions
cancer therapy
sapogenin
saponin
pharmaceutical
Prior art date
Application number
BR0311866-5A
Other languages
English (en)
Inventor
Dong Huang
Original Assignee
Panagin Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA002390290A external-priority patent/CA2390290A1/en
Application filed by Panagin Pharmaceuticals Inc filed Critical Panagin Pharmaceuticals Inc
Publication of BR0311866A publication Critical patent/BR0311866A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Reproductive Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

"COMPOSIçõES DE SAPONINAS OU SAPOGENINAS PARA TERAPIA DE CâNCER". Onde são providas composições para terapia de câncer compreendendo duas ou mais saponinas e/ou sapogeninas. As composições intensificaram a atividade anticâncer quando comparadas a cada componente individual utilizado sozinho. Também, são providas formulações farmacêuticas e não farmacêuticas compreendendo as composições para uso no tratamento de indivíduos mamíferos com câncer, e kits farmacêuticos compreendendo estas composições ou formulações.
BR0311866-5A 2002-06-11 2003-06-11 Composições de saponinas ou sapogeninas para terapia de câncer BR0311866A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002390290A CA2390290A1 (en) 2002-06-11 2002-06-11 Protopanaxadiol and protopanaxatriol and their use as anti-cancer agents
US43530502P 2002-12-23 2002-12-23
PCT/CA2003/000847 WO2003103682A1 (en) 2002-06-11 2003-06-11 Compositions for cancer therapy saponins or sapogenins

Publications (1)

Publication Number Publication Date
BR0311866A true BR0311866A (pt) 2005-03-15

Family

ID=29737444

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0311866-5A BR0311866A (pt) 2002-06-11 2003-06-11 Composições de saponinas ou sapogeninas para terapia de câncer

Country Status (7)

Country Link
US (1) US20060013897A1 (pt)
EP (1) EP1519733A1 (pt)
JP (1) JP2005534654A (pt)
AU (1) AU2003233733A1 (pt)
BR (1) BR0311866A (pt)
RU (1) RU2004137801A (pt)
WO (1) WO2003103682A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003287834A1 (en) * 2002-12-19 2004-07-14 Panagin Pharmaceuticals Inc. Use of aglycon protopanaxadiol in cancer therapy
AU2003287833A1 (en) * 2002-12-19 2004-07-14 Panagin Pharmaceuticals Inc. Use of aglycon protopanaxatriol in cancer therapy
ES2395818T3 (es) * 2004-07-13 2013-02-15 Charite - Universitatsmedizin Berlin Composición que comprende un agente farmacológicamente activo acoplado a un componente específico de célula diana, y una saponina
CN100423727C (zh) * 2006-01-19 2008-10-08 云南天秀植物科技开发有限公司 一种抗肿瘤的药物组合物及其制备工艺
KR100828192B1 (ko) * 2006-05-10 2008-05-08 주식회사 진생사이언스 담마란계 화합물을 유효성분으로 포함하는 신장 보호용약학 조성물
JP2009055796A (ja) * 2007-08-30 2009-03-19 Shionogi & Co Ltd 延命評価モデル
US8217165B2 (en) * 2008-06-17 2012-07-10 Pawan Kumar Goel Process for the extraction of furostanolic saponins from fenugreek seeds
WO2010029915A1 (ja) * 2008-09-09 2010-03-18 ライオン株式会社 サポゲニン高含有組成物の製造方法
JP5563285B2 (ja) * 2009-12-14 2014-07-30 ライオン株式会社 飲食品、医薬品、又は医薬部外品、並びに、プロトパナキサトリオールの安定化方法、及びプロトパナキサジオールの安定化方法
CN101890040B (zh) * 2010-07-27 2011-12-21 上海中药创新研究中心 一种具有抗疲劳作用的组合物及其应用
WO2014178802A1 (en) * 2013-04-29 2014-11-06 Alkoçlar Redal Can A protopanaxtriol composition for the treatment of prostate cancer and benign prostatic hyperplasia
KR101595426B1 (ko) 2013-08-30 2016-02-18 (주)녹십자웰빙 진세노사이드 성분이 증가된 가공인삼분말 또는 가공인삼추출물을 함유하는 암 관련 피로의 예방 및 치료용 조성물
KR101733665B1 (ko) * 2015-05-06 2017-05-10 재단법인 지능형 바이오 시스템 설계 및 합성 연구단 진세노사이드 Ｆ1 또는 Ｒｇ3을 유효성분으로 포함하는 글리벡 내성 백혈병 예방 또는 치료용 약학 조성물
KR101946282B1 (ko) * 2015-07-16 2019-04-22 주식회사 씨엔에이치코퍼레이션 생약 성분을 포함하는 유방암 예방 또는 치료용 조성물
KR102371418B1 (ko) * 2017-05-19 2022-03-08 (주)아모레퍼시픽 프로토파낙사트리올을 포함하는 피부 미백용 조성물
CN113082039B (zh) * 2021-03-30 2023-01-13 香港浸会大学深圳研究院 一种用于治疗索拉菲尼耐药肿瘤的组合物及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2828851A1 (de) * 1978-06-30 1980-01-10 Shigeru Arichi Neue antitumormittel
JPS55129228A (en) * 1979-03-24 1980-10-06 Osaka Chem Lab Cell-activating agent
JPS58131999A (ja) * 1982-01-30 1983-08-06 Osaka Chem Lab 抗腫瘍剤
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
WO2001082908A2 (en) * 2000-05-01 2001-11-08 The University Of British Columbia Ginsenoside chemotherapy
US20030092638A1 (en) * 2001-09-21 2003-05-15 Dong Huang Protopanaxadiol and protopanaxatriol and their use as anti-cancer agents

Also Published As

Publication number Publication date
WO2003103682A1 (en) 2003-12-18
US20060013897A1 (en) 2006-01-19
JP2005534654A (ja) 2005-11-17
EP1519733A1 (en) 2005-04-06
RU2004137801A (ru) 2005-10-10
AU2003233733A1 (en) 2003-12-22

Similar Documents

Publication Publication Date Title
BR0311866A (pt) Composições de saponinas ou sapogeninas para terapia de câncer
BRPI0510428A (pt) composições tópicas de metadona e processos para utilização das mesmas
BR0316050A (pt) Métodos de tratar, controlar ou prevenir um câncer especìfico e doença associada com angiogênese indesejada e de reduzir ou evitar um efeito adverso associado com a administração de um segundo ingrediente ativo e com terapia de radiação, terapia hormonal, terapia biológica, ou imunoterapia em um paciente sofrendo de um câncer especìfico, composição farmacêutica e kit
DE60313597D1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
BR0309875A (pt) métodos e composições para tratamento de distúrbios do sistema nervoso periférico e novos compostos úteis para isto
BR0214343A (pt) Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1
BR0308429A (pt) Aroilpiridinonas monocìclicas como agentes antiinflamatórios
BRPI0512410A (pt) compostos de amido e seu uso como produtos farmacêuticos
WO2006044916A3 (en) Use of na+/ k+-atpase inhibitors and antagonists thereof
BR0108678A (pt) Novos compostos
ATE330959T1 (de) Allosterische adenosin-rezeptor-modulatore
DK0781281T3 (da) Beta-Carbolinderivater som melatonin-agonister, fremgangsmåder til fremstilling deraf og deres anvendelse som lægemiddel
DK1259240T3 (da) Midler, såsom nikotinamid eller CADPR, til behandling af hudsygdomme
NZ308789A (en) Tetralin derivatives and medicaments
BRPI0414721A (pt) formulações estabilizadas de fosfatidilserina
BR0314797A (pt) Derivados da pirimidineamida e o uso dos mesmos
BRPI0416275A (pt) métodos de tratar, controlar ou prevenir um cáncer especìfico e uma doença associada com angiogênese indesejada
BR0012610A (pt) Novo derivado de difenilpiperidina
DE69718734D1 (de) Bicyclische aromatische verbindungen
BR0108728A (pt) Combinação farmacêutica terapêutica, e, método para tratar um c ncer.
WO2004096159A3 (en) Saposin c-dops: a novel anti-tumor agent
DK0823903T3 (da) Heterocykliske biarylforbindelser, farmaceutiske præparater og kosmetiske sammensætninger, der indeholder dem, og anvendelser
CY1108266T1 (el) Παραγωγα διβενζο(c) χρωμεν-6-ονης ως αντικαρκινικοι παραγοντες
DE69422712D1 (de) Tris-platin-komplexe
BR0113165A (pt) Derivados de 4-pirimidinamina, composições farmacêuticas e métodos relacionados

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/56 (2006.01), A61K 36/258 (2006.01), A61P